232 related articles for article (PubMed ID: 20940707)
1. Sulforaphane increases drug-mediated cytotoxicity toward cancer stem-like cells of pancreas and prostate.
Kallifatidis G; Labsch S; Rausch V; Mattern J; Gladkich J; Moldenhauer G; Büchler MW; Salnikov AV; Herr I
Mol Ther; 2011 Jan; 19(1):188-95. PubMed ID: 20940707
[TBL] [Abstract][Full Text] [Related]
2. Synergistic activity of sorafenib and sulforaphane abolishes pancreatic cancer stem cell characteristics.
Rausch V; Liu L; Kallifatidis G; Baumann B; Mattern J; Gladkich J; Wirth T; Schemmer P; Büchler MW; Zöller M; Salnikov AV; Herr I
Cancer Res; 2010 Jun; 70(12):5004-13. PubMed ID: 20530687
[TBL] [Abstract][Full Text] [Related]
3. Sulforaphane, a dietary component of broccoli/broccoli sprouts, inhibits breast cancer stem cells.
Li Y; Zhang T; Korkaya H; Liu S; Lee HF; Newman B; Yu Y; Clouthier SG; Schwartz SJ; Wicha MS; Sun D
Clin Cancer Res; 2010 May; 16(9):2580-90. PubMed ID: 20388854
[TBL] [Abstract][Full Text] [Related]
4. Targeting of pancreatic and prostate cancer stem cell characteristics by Crambe crambe marine sponge extract.
Ottinger S; Klöppel A; Rausch V; Liu L; Kallifatidis G; Gross W; Gebhard MM; Brümmer F; Herr I
Int J Cancer; 2012 Apr; 130(7):1671-81. PubMed ID: 21544815
[TBL] [Abstract][Full Text] [Related]
5. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation.
Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I
Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157
[TBL] [Abstract][Full Text] [Related]
6. Dietary polyphenol quercetin targets pancreatic cancer stem cells.
Zhou W; Kallifatidis G; Baumann B; Rausch V; Mattern J; Gladkich J; Giese N; Moldenhauer G; Wirth T; Büchler MW; Salnikov AV; Herr I
Int J Oncol; 2010 Sep; 37(3):551-61. PubMed ID: 20664924
[TBL] [Abstract][Full Text] [Related]
7. Sonic hedgehog signaling inhibition provides opportunities for targeted therapy by sulforaphane in regulating pancreatic cancer stem cell self-renewal.
Rodova M; Fu J; Watkins DN; Srivastava RK; Shankar S
PLoS One; 2012; 7(9):e46083. PubMed ID: 23029396
[TBL] [Abstract][Full Text] [Related]
8. Sulforaphane and TRAIL induce a synergistic elimination of advanced prostate cancer stem-like cells.
Labsch S; Liu L; Bauer N; Zhang Y; Aleksandrowicz E; Gladkich J; Schönsiegel F; Herr I
Int J Oncol; 2014 May; 44(5):1470-80. PubMed ID: 24626333
[TBL] [Abstract][Full Text] [Related]
9. Broccoli extract increases drug-mediated cytotoxicity towards cancer stem cells of head and neck squamous cell carcinoma.
Elkashty OA; Tran SD
Br J Cancer; 2020 Oct; 123(9):1395-1403. PubMed ID: 32773768
[TBL] [Abstract][Full Text] [Related]
10. Sulforaphane targets cancer stemness and tumor initiating properties in oral squamous cell carcinomas via miR-200c induction.
Liu CM; Peng CY; Liao YW; Lu MY; Tsai ML; Yeh JC; Yu CH; Yu CC
J Formos Med Assoc; 2017 Jan; 116(1):41-48. PubMed ID: 26879838
[TBL] [Abstract][Full Text] [Related]
11. Combined gemcitabine and CHK1 inhibitor treatment induces apoptosis resistance in cancer stem cell-like cells enriched with tumor spheroids from a non-small cell lung cancer cell line.
Fang DD; Cao J; Jani JP; Tsaparikos K; Blasina A; Kornmann J; Lira ME; Wang J; Jirout Z; Bingham J; Zhu Z; Gu Y; Los G; Hostomsky Z; Vanarsdale T
Front Med; 2013 Dec; 7(4):462-76. PubMed ID: 23820871
[TBL] [Abstract][Full Text] [Related]
12. Synergistic antitumor interaction of valproic acid and simvastatin sensitizes prostate cancer to docetaxel by targeting CSCs compartment via YAP inhibition.
Iannelli F; Roca MS; Lombardi R; Ciardiello C; Grumetti L; De Rienzo S; Moccia T; Vitagliano C; Sorice A; Costantini S; Milone MR; Pucci B; Leone A; Di Gennaro E; Mancini R; Ciliberto G; Bruzzese F; Budillon A
J Exp Clin Cancer Res; 2020 Oct; 39(1):213. PubMed ID: 33032653
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphane, quercetin and catechins complement each other in elimination of advanced pancreatic cancer by miR-let-7 induction and K-ras inhibition.
Appari M; Babu KR; Kaczorowski A; Gross W; Herr I
Int J Oncol; 2014 Oct; 45(4):1391-400. PubMed ID: 25017900
[TBL] [Abstract][Full Text] [Related]
14. JNK pathway inhibition selectively primes pancreatic cancer stem cells to TRAIL-induced apoptosis without affecting the physiology of normal tissue resident stem cells.
Recio-Boiles A; Ilmer M; Rhea PR; Kettlun C; Heinemann ML; Ruetering J; Vykoukal J; Alt E
Oncotarget; 2016 Mar; 7(9):9890-906. PubMed ID: 26840266
[TBL] [Abstract][Full Text] [Related]
15. Cucurbitacin I suppressed stem-like property and enhanced radiation-induced apoptosis in head and neck squamous carcinoma--derived CD44(+)ALDH1(+) cells.
Chen YW; Chen KH; Huang PI; Chen YC; Chiou GY; Lo WL; Tseng LM; Hsu HS; Chang KW; Chiou SH
Mol Cancer Ther; 2010 Nov; 9(11):2879-92. PubMed ID: 21062915
[TBL] [Abstract][Full Text] [Related]
16. Sulforaphane targets pancreatic tumour-initiating cells by NF-kappaB-induced antiapoptotic signalling.
Kallifatidis G; Rausch V; Baumann B; Apel A; Beckermann BM; Groth A; Mattern J; Li Z; Kolb A; Moldenhauer G; Altevogt P; Wirth T; Werner J; Schemmer P; Büchler MW; Salnikov AV; Herr I
Gut; 2009 Jul; 58(7):949-63. PubMed ID: 18829980
[TBL] [Abstract][Full Text] [Related]
17. Notch pathway inhibition using DAPT, a γ-secretase inhibitor (GSI), enhances the antitumor effect of cisplatin in resistant osteosarcoma.
Dai G; Deng S; Guo W; Yu L; Yang J; Zhou S; Gao T
Mol Carcinog; 2019 Jan; 58(1):3-18. PubMed ID: 29964327
[TBL] [Abstract][Full Text] [Related]
18. A direct pancreatic cancer xenograft model as a platform for cancer stem cell therapeutic development.
Jimeno A; Feldmann G; Suárez-Gauthier A; Rasheed Z; Solomon A; Zou GM; Rubio-Viqueira B; García-García E; López-Ríos F; Matsui W; Maitra A; Hidalgo M
Mol Cancer Ther; 2009 Feb; 8(2):310-4. PubMed ID: 19174553
[TBL] [Abstract][Full Text] [Related]
19. Sulforaphane synergizes with quercetin to inhibit self-renewal capacity of pancreatic cancer stem cells.
Srivastava RK; Tang SN; Zhu W; Meeker D; Shankar S
Front Biosci (Elite Ed); 2011 Jan; 3(2):515-28. PubMed ID: 21196331
[TBL] [Abstract][Full Text] [Related]
20. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer.
Jiang F; Qiu Q; Khanna A; Todd NW; Deepak J; Xing L; Wang H; Liu Z; Su Y; Stass SA; Katz RL
Mol Cancer Res; 2009 Mar; 7(3):330-8. PubMed ID: 19276181
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]